Physician profile
Christopher H Bratton
NPI 1831190057
$589.38
in general payments reported to CMS, 2019-2025
19 companies · $39.28 in 2025
The $39.28 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $84.85 · 2021: $127 · 2022: $77.32 · 2023: $84.95 · 2024: $67.73 · 2025: $39.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $106.70 | 2020-2022 | |
| Dexcom, INC. | $75.75 | 2020-2023 | Dexcom G6 Transmitter |
| Abbvie INC. | $62.40 | 2022-2024 | |
| Boston Scientific Corporation | $51.77 | 2019-2023 | Spyglass |
| Janssen Pharmaceuticals, INC | $45.59 | 2019-2020 | |
| Abbott Laboratories | $24.56 | 2021 | |
| Redhill Biopharma INC. | $23.96 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $21.26 | 2025 | Rexulti |
| Olympus America INC. | $21.06 | 2023 | |
| Hologic Sales and Service, LLC | $20.39 | 2024 | Aptima |
| Smith+Nephew, INC. | $20.32 | 2023 | Stravix |
| Medtronic, INC. | $18.02 | 2025 | Truclear |
| Glaxosmithkline, LLC. | $17.43 | 2020 | |
| Amarin Pharma, INC. | $15.10 | 2019 | |
| Sanofi Pasteur INC. | $14.49 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.44 | 2021 | |
| Sanara Medtech INC. | $13.09 | 2023 | Celleraterx |
| Almatica Pharma LLC | $12.80 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bratton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.